Your shopping cart is currently empty

Perfluorohexane (AF-0150), a perfluorocarbon (PFC)-based microbubble formulation, is an ultrasound contrast agent with developmental toxicity that induces memory deficits and neuroprotein downregulation through the NMDA receptor-mediated PKC-ERK/AMPK signaling pathway.Perfluorohexane interferes with estrous cycle, ovulation rate in mice, Perfluorohexane interferes with estrous cycle, ovulation rate, oocyte communication and calcium homeostasis in mice.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 g | $30 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $29 | - | In Stock |
| Description | Perfluorohexane (AF-0150), a perfluorocarbon (PFC)-based microbubble formulation, is an ultrasound contrast agent with developmental toxicity that induces memory deficits and neuroprotein downregulation through the NMDA receptor-mediated PKC-ERK/AMPK signaling pathway.Perfluorohexane interferes with estrous cycle, ovulation rate in mice, Perfluorohexane interferes with estrous cycle, ovulation rate, oocyte communication and calcium homeostasis in mice. |
| Synonyms | Perflexane, AF-0150, AF0150 |
| Molecular Weight | 338.04 |
| Formula | C6F14 |
| Cas No. | 355-42-0 |
| Smiles | FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F |
| Relative Density. | 1.669 g/cm3 at 25℃ (lit.) |
| Storage | -20°C for 2 years, 4°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 125 mg/mL (369.78 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (9.76 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.